A rapid point-of-care test for early prediction diabetic foot ulcer pathogenesis

早期预测糖尿病足溃疡发病机制的快速护理点测试

• 批准号: 10047069
• 金额: $ 6.37万
• 依托单位: CROMERIX LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10047069
• 关键词: rapid; point; care; test; early

Diabetic foot ulcer is a severe healthcare problem that is associated with significant morbidity, costs, and mortality. A low-cost simple and rapid point-of-care test that can help predict infection in diabetic foot ulcers (DFU) and inform optimal and timely self-driven management at home and in the community will have a significant impact on quality of life, care, and costs. We will carry out the technological and commercial feasibility of such a test under development. We will adapt our novel microbial test to work for DFU, receive clinical feedback on its validation data and develop a commercial plan working together with industry specialists, clinical experts, and patients/public.

糖尿病足溃疡是一个严重的医疗保健问题，与显着的发病率，成本和死亡率。一种低成本的简单快速的护理点测试可以帮助预测糖尿病足溃疡（DFU）的感染，并在家中和社区提供最佳和及时的自我驱动管理，这将对生活质量，护理和成本产生重大影响。我们将对正在开发的这种试验进行技术和商业可行性研究。我们将调整我们的新型微生物测试以适用于DFU，接收有关其验证数据的临床反馈，并与行业专家，临床专家和患者/公众合作制定商业计划。